AVANIR

Photos: The Multiple Sclerosis Association of America Produces a Web Video on the Importance of MRIs

...velopment and implementation of MSi is made possible through the funding support of EMD Serono, Inc. and Pfizer Inc, Bayer HealthCare Pharmaceuticals, avanir Pharmaceuticals, Medtronic Foundation, and The Horizon Foundation for New Jersey. For more information on this program, MSAA, or any of the programs...

AVANIR in Medical Technology

Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain

...Senior Vice President and Chief Medical Officer of avanir Pharmaceuticals. "We look forward to meeting with ... pain," said Keith A. Katkin, President and CEO of avanir Pharmaceuticals. "Avanir now has two Phase III Zen... Diabetes Association. About the Study In 2005 avanir initiated a randomized double-blind, placebo-contr...

Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia Long-Term Safety Data at AAN Annual Meeting

...uinidine dose formulation of Zenvia. In April 2007 avanir completed the first of two planned phase III studi... for diabetic peripheral neuropathic pain. About avanir avanir Pharmaceuticals is focused on developing, acquirin...

AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at Second International Congress on Neuropathic Pain

...," said Randall Kaye, MD, Chief Medical Officer of avanir Pharmaceuticals. The accepted posters are: -- ...DIABETIC PERIPHERAL NEUROPATHY On April 18, 2007 avanir Pharmaceuticals announced positive top-line result...uinidine dose formulation of Zenvia. In April 2007 avanir completed the first of two planned Phase III studi...

AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at International Congress on Neuropathic Pain

...uinidine dose formulation of Zenvia. In April 2007 avanir completed a Phase III study in patients with diabe...hase III trial being planned for DPN pain. About avanir avanir Pharmaceuticals is focused on developing, acquirin...

AVANIR in Biological Technology

David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO

... represents an evolution for patient care in the hospital setting." Dr. Mazzo currently is Non-Executive Chairman of Psivida, Inc. and a Director of avanir Pharmaceuticals. He earned a Bachelor of Arts degree in the Honors Program (Interdisciplinary Humanities) and a Bachelor of Science degree in Chemistr...